Prognostic and Clinical Significance of Aspartate Aminotransferase-to-Lymphocyte Ratio Index in Individuals with Liver Cancer: A Meta-Analysis

Table 3

Correlations of ALRI and clinical factors in patients with hepatocellular carcinoma.

Characteristics	No. of studies	No. of patients	Effects model	OR (95% CI)		Heterogeneity
						^2 (%)
Sex, male vs. female	6	1995	Random	1.32 (1.02-1.70)	0.035	0	0.613
Age, years, >60 vs. ≤60	3	475	Random	0.89 (0.56-1.43)	0.637	0	0.630
HBsAg, positive vs. negative	5	1566	Random	1.26 (0.95-1.67)	0.104	0	0.410
AFP, ng/ml, >400 vs. ≤400	4	1418	Random	1.45 (0.89-2.37)	0.136	71.9	0.014
Cirrhosis, yes vs. no	5	1566	Random	1.68 (1.01-2.81)	0.046	63	0.029
Tumor size, ≥5 cm vs. <5 cm	5	1566	Random	2.25 (1.31-3.88)	0.003	81	<0.001
Tumor number, multiple vs. single	4	1360	Random	1.19 (0.87-1.64)	0.271	0	0.685
TNM stage, III-IV vs. I-II	4	1246	Random	1.94 (0.97-3.90)	0.062	87.6	<0.001
PVTT, yes vs. no	4	1069	Random	2.50 (1.52-4.11)	<0.001	47.4	0.127
Distant metastasis, yes vs.no	3	878	Random	1.72 (1.05-2.82)	0.031	0	0.472